The RENEW Trial: A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Adaptive Phase 3 Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease
Study sponsor: Aldeyra Therapeutics, Inc. · ALDX
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2019-10-04Actual
Enrollment · participants422Actual
Source updated2025-01-23Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.